
| Salt Composition: | Cefuroxime (500mg) + Clavulanic Acid (125mg) |
| Manufacturer: | Intra Life |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Motocef CV 625 Tablet is a combination medicine used to treat various types of bacterial infections by preventing the growth and spread of microorganisms. Motocef CV 625 Tablet is a prescription medicine used to treat bacterial infections. It can be taken with or without food but should be taken at a fixed time for better efficacy. Do not exceed the recommended dose as it may have harmful effects. Complete the full course of treatment even if you feel better to avoid the recurrence of infection. Common side effects include nausea, vomiting, diarrhea, and indigestion. Seek immediate medical help if you experience any allergic reactions. Consult your doctor if you are pregnant, breastfeeding, or taking other medications. Avoid alcohol as it can cause drowsiness. Ensure adequate rest, a healthy diet, and plenty of water for faster recovery. Your doctor may recommend laboratory tests to monitor the effects of the medicine.
Motocef CV 625 Tablet is a combination of Cefuroxime and Clavulanic Acid. Cefuroxime prevents the formation of the bacterial protective covering essential for bacterial survival. Clavulanic Acid blocks enzymes produced by bacteria to inactivate Cefuroxime, reducing resistance and enhancing its activity against bacteria.
Take this medicine in the dose and duration as advised by your doctor. Swallow it whole without chewing, crushing, or breaking it. It can be taken with or without food but is better taken at a fixed time.
Alcohol
Consuming alcohol with Motocef CV 625 Tablet does not cause any harmful side effects.
Breastfeed
Motocef CV 625 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into breastmilk in significant amounts and is not harmful to the baby.
Pregnancy
Motocef CV 625 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.